Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Mallinckrodt
Federal Trade Commission
UBS
Farmers Insurance
Johnson and Johnson
Daiichi Sankyo
Cipla

Generated: April 22, 2018

DrugPatentWatch Database Preview

KEFUROX IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Kefurox In Plastic Container, and when can generic versions of Kefurox In Plastic Container launch?

Kefurox In Plastic Container is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in KEFUROX IN PLASTIC CONTAINER is cefuroxime sodium. There are sixty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
Summary for KEFUROX IN PLASTIC CONTAINER
Drug patent expirations by year for KEFUROX IN PLASTIC CONTAINER
Synonyms for KEFUROX IN PLASTIC CONTAINER
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-furanyl(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt
3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt (6R-(6alpha,7beta(Z)))-
55268-75-2
56238-63-2
AB53970
AC-15028
AKOS015961772
AN-40200
Anaptivan
ANAPTIVAN SODIUM SALT
BC208459
Biociclin
BIOCICLIN SODIUM SALT
Biofurex
BIOFUREX SODIUM SALT
Biofuroksym
Bioxima
C08108
C16H15N4O8S.Na
CCG-220720
Cefofix
Cefumax
Cefurex
Cefuril
Cefurin
CEFURIN SODIUM SALT
Cefuroxim
Cefuroxim AJ
Cefuroxim curasan
Cefuroxim Fresenius
Cefuroxim Genericsn
Cefuroxim Hexal
Cefuroxim Lilly
Cefuroxim MN
Cefuroxim Norcox
Cefuroxim Norcox [inj.]
Cefuroxima Fabra
Cefuroxima Richet
cefuroxime
Cefuroxime (sodium)
Cefuroxime (TN)
Cefuroxime (USAN/INN)
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
Cefuroxime for Injection and Dextrose for Injection in Duplex Container
cefuroxime na
CEFUROXIME SODIUM
Cefuroxime sodium (JAN/USP)
Cefuroxime sodium (JP15/USP)
Cefuroxime sodium [USAN:BAN:JAN]
Cefuroxime sodium [USP:BAN:JAN]
Cefuroxime sodium salt
Cefuroxime sodium, European Pharmacopoeia (EP) Reference Standard
Cefuroxime sodium, United States Pharmacopeia (USP) Reference Standard
cefuroximesodium
Cefuroximine
Cetroxil
Cetroxil [inj.]
CHEBI:3517
CHEMBL2146124
Colifossim
CS-4733
Curocef
Curoxim
Curoxima
Curoxime
CXM
D00915
D0Y2IE
Duxima
DUXIMA SODIUM SALT
EINECS 260-073-1
Froxal
Froxal [inj.]
Furoxil
HMS2097O21
HY-B1256
Kefurox
Kesint
Ketocef
KS-1040
Lifurox
LS-149936
Medoxim
MLS000069576
MLS001332625
MLS001332626
MolPort-002-885-814
Novocef
NOVOCEF SODIUM SALT
R8A7M9MY61
s4620
SCHEMBL719536
Sharox
Sharox [inj.]
SMR000058808
Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
sodium (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester)
Sodium cefuroxime
sodium;(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Spectrazolr
Ultroxim
UNII-R8A7M9MY61
Zinacef
Zinacef (TN)
ZINACEF IN PLASTIC CONTAINER
ZINACEF SODIUM SALT
Zinnat (TN)
Zinnat [inj.]

US Patents and Regulatory Information for KEFUROX IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly KEFUROX IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 062590-002 Jan 10, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly KEFUROX IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INTRAVENOUS 062590-001 Jan 10, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Express Scripts
McKinsey
Mallinckrodt
Covington
Federal Trade Commission
Boehringer Ingelheim
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.